T, D., K, P., AM, T., JF, S., J, W., S, L., . . . M, C. (2026). World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors. Transplantation and cellular therapy, 32(5), 551.e1-551.e6. https://doi.org/10.1016/j.jtct.2026.01.021
Chicago Style (17th ed.) CitationT, Dexter, et al. "World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors." Transplantation and Cellular Therapy 32, no. 5 (2026): 551.e1-551.e6. https://doi.org/10.1016/j.jtct.2026.01.021.
MLA (9th ed.) CitationT, Dexter, et al. "World Marrow Donor Association Statement on the Use of Plerixafor in Healthy Donors." Transplantation and Cellular Therapy, vol. 32, no. 5, 2026, pp. 551.e1-551.e6, https://doi.org/10.1016/j.jtct.2026.01.021.